Histone Deacetylase Inhibitor [EPC]

2641 reported adverse events

Drugs of this class: BELINOSTAT ROMIDEPSIN VORINOSTAT

These side effects are most commonly reported by patients taking drugs of the Histone Deacetylase Inhibitor [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 237
1 NAUSEA 199
2 THROMBOCYTOPENIA 184
3 ANAEMIA 183
4 FATIGUE 174
5 DIARRHOEA 164
6 VOMITING 163
7 PYREXIA 139
8 PLATELET COUNT DECREASED 128
9 SEPSIS 128
See all common reactions for Histone Deacetylase Inhibitor [EPC]

Drugs of the Histone Deacetylase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CD34 CELL COUNT DECREASED 2 0.5000
1 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 18 0.3462
2 MYCOSIS FUNGOIDES REFRACTORY 2 0.3333
3 OVARIAN EPITHELIAL CANCER STAGE III 2 0.1818
4 CUTANEOUS T-CELL LYMPHOMA STAGE II 1 0.0909
5 ANORECTAL INFECTION BACTERIAL 1 0.0909
6 RHINITIS ATROPHIC 2 0.0870
7 CHEMOTHERAPY CARDIOTOXICITY ATTENUATION 1 0.0833
8 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT 1 0.0833
9 MYCOSIS FUNGOIDES RECURRENT 2 0.0690
See all enriched reactions for Histone Deacetylase Inhibitor [EPC]